Search results for "CANDIDA"

showing 10 items of 844 documents

The loss of the inducible Aspergillus carbonarius MFS transporter MfsA leads to ochratoxin A overproduction

2014

Ochratoxin A (OTA), a nephrotoxic compound produced by certain Aspergillus and Penicillium species, is one of the most abundant mycotoxins in food commodities. Aspergillus carbonarius is the main source of OTA in wine, grape juice and dried vine fruits. Although many studies have focused on OTA production by A. carbonarius, little is known about the genes related to OTA production and transport. We have found a transporter that belongs to the major facilitator superfamily (MfsA) which is highly expressed with a 102-fold induction in an ochratoxigenic A. carbonarius strain compared to a low OTA producer strain. The encoding mfsA gene shows similarity to the multidrug efflux transporter flu1 …

Ochratoxin AOchratoxin productionGrapesGenes FungalMolecular Sequence DataWineAspergillus carbonariusBiologyMicrobiologyMicrobiologychemistry.chemical_compoundGene Expression Regulation FungalmfsAPromoter Regions GeneticOverproductionCandida albicansMycotoxinMajor facilitator superfamily transportersAspergillusBinding SitesBase Sequencefood and beveragesTransporterGeneral Medicinebiology.organism_classificationOchratoxinsMajor facilitator superfamilyOxidative StressAspergilluschemistryFruitEffluxGene DeletionFood ScienceInternational Journal of Food Microbiology
researchProduct

Type A competitiveness traits correlate with downregulation of c-Fos expression in patients with type 1 diabetes.

2019

International audience; AimType A personality has been associated with increased survival in people with type 1 diabetes (T1D). Systemic low-grade inflammation may play a critical role, as suggested in recent reports, although the links between the inflammatory circulating transcriptome and Type A remain unknown. This prompted our exploration of the potential associations between Type A personality and c-Fos gene expression, a candidate gene closely linked to inflammatory processes, in T1D.MethodsType A personality was assessed by Bortner questionnaire in patients with T1D, and two subscales – ‘speed’ and ‘competitiveness’ – were used to measure these specific dimensions of Type A. Expressi…

OncologyAdultMalemedicine.medical_specialtyCandidate geneInverse AssociationCompetitive BehaviorEndocrinology Diabetes and MetabolismDown-RegulationGene Expression030209 endocrinology & metabolismPilot Projects030204 cardiovascular system & hematologyType ATranscriptomeCohort Studies03 medical and health sciencesddc:616.890302 clinical medicineEndocrinologyInternal medicineGene expressionInternal MedicinemedicineHumansGene[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismInflammationType 1 diabetesc-FosBlood Cellsbusiness.industryGene Expression ProfilingDiabetesType A and Type B personality theoryType A PersonalityGeneral Medicine[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle Agedmedicine.diseaseCompetitivenessDiabetes Mellitus Type 1businessBody mass indexProto-Oncogene Proteins c-fosDiabetic AngiopathiesPersonalityDiabetesmetabolism
researchProduct

PO-324 Detection of high-risk prostate cancer biomarkers by RNA sequencing and qPCR method

2018

Introduction New prognostic biomarkers for prostate cancer have the potential to overcome the clinical challenge of therapy decision and overtreatment. Present diagnostic and prognostic tests are still limited in specificity resulting in a large number of false positives and unnecessary biopsies. Furthermore, they do not enable a proper stratification between men with a high risk for an aggressive disease course requiring comprehensive therapy scheme after surgery and men with a low risk of disease recurrence cured after prostatectomy or eligible for active surveillance. In particular, patients with Gleason score 6 and 7 tumours (low and mid stage) are difficult to stratify for the appropri…

OncologyCancer ResearchCandidate genemedicine.medical_specialtyTumour heterogeneitybusiness.industryProstatectomymedicine.medical_treatmentCancerDiseasemedicine.diseaseFusion geneProstate cancerOncologyInternal medicinemedicineStage (cooking)businessESMO Open
researchProduct

Genetic determinants of ototoxicity during and after childhood cancer treatment: Protocol for the pancarelife study

2019

BACKGROUND: Survival rates after childhood cancer now reach nearly 80% in developed countries. However, treatments that lead to survival and cure can cause serious adverse effects with lifelong negative impacts on survivor quality of life. Hearing impairment is a common adverse effect in children treated with cisplatin-based chemotherapy or cranial radiotherapy. Ototoxicity can extend from high-tone hearing impairment to involvement of speech frequencies. Hearing impairment can impede speech and language and neurocognitive development. Although treatment-related risk factors for hearing loss following childhood cancer treatment have been identified, the individual variability in toxicity of…

OncologyCandidate gene020205 medical informaticscisplatinCHILDREN02 engineering and technologyVARIANTSPLATINUM-INDUCED OTOTOXICITYChildhood cancer survivors0302 clinical medicineTPMT0202 electrical engineering electronic engineering information engineeringProtocolGWASgenetics030212 general & internal medicineSURVIVORSGeneral MedicineCHEMOTHERAPY3. Good healthototoxicityCohortmedicine.symptomcandidate genes020 Library & information sciencesmedicine.medical_specialtyINDUCED HEARING-LOSSHearing losschildhood cancer survivors610 Medicine & healthINTERNATIONAL SOCIETYCandidate genes03 medical and health sciencesACYP2OtotoxicitySDG 3 - Good Health and Well-being360 Social problems & social servicesInternal medicinemedicineGenetic predispositionGeneticsCISPLATIN-INDUCED OTOTOXICITYAdverse effecthearing lossbusiness.industryCancerHearing lossmedicine.diseaseOtotoxicityClinical trialCisplatinbusinessPolymorphismspolymorphisms
researchProduct

Association of candidate pharmacogenetic markers with platinum-induced ototoxicity

2020

Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (TPMT) is considered a critical gene for susceptibility to cisplatin-induced hearing loss in a pharmacogenetic guideline. The PanCareLIFE cross-sectional cohort study evaluated the genetic associations in a large pan-European population and assessed the diagnostic accuracy of the genetic markers. 1,112 pediatric cancer survivors who had provided biomaterial for genotyping were screened for participation in the pharmacogenetic association study. 900 participants qualified for inclusion. Based on the assessment of original audiograms, patien…

OncologyDrug-induced ototoxicitymedicine.medical_specialtyCandidate geneHearing lossMulticenter cohort studyCancer survivorsPopulationAdverse drug reaction610 Medicine & healthlcsh:Computer applications to medicine. Medical informatics03 medical and health sciences0302 clinical medicine360 Social problems & social servicesInternal medicinemedicineGenetic predisposition610 Medicine & healtheducationlcsh:Science (General)030304 developmental biologyGenetic association0303 health scienceseducation.field_of_studyMultidisciplinaryThiopurine methyltransferasebiologycarboplatin [Cisplatin]business.industryMedicine and DentistryPediatric cancerCisplatin: carboplatinPharmacogeneticsbiology.proteinlcsh:R858-859.7Genetic markersmedicine.symptombusinessChildhood cancer360 Social problems & social services030217 neurology & neurosurgeryPharmacogeneticslcsh:Q1-390Data in brief
researchProduct

Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene appr…

2021

Background: Female childhood cancer survivors (CCSs) carry a risk of therapy-related gonadal dysfunction. Alkylating agents (AA) are well-established risk factors, yet inter-individual variability in ovarian function is observed. Polymorphisms in CYP450 enzymes may explain this variability in AA-induced ovarian damage. We aimed to evaluate associations between previously identified genetic polymorphisms in CYP450 enzymes and AA-related ovarian function among adult CCSs. Methods: Anti-Müllerian hormone (AMH) levels served as a proxy for ovarian function in a discovery cohort of adult female CCSs, from the pan-European PanCareLIFE cohort (n = 743

OncologyInfertilityCancer ResearchCandidate genemedicine.medical_specialtyendocrine systemendocrine system diseasesMedizinAnti-Müllerian hormoneArticleHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]Childhood cancer survivors03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingInterquartile rangeInternal medicineGenetic variationGenetic modelmedicineChemotherapyFertility preservationRC254-282030304 developmental biology0303 health sciencesbiologybusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensAnti-Müllerian hormonemedicine.diseaseOvarian functionCytochrome P450 genesWomen's cancers Radboud Institute for Health Sciences [Radboudumc 17]3. Good healthOncology030220 oncology & carcinogenesisCohortbiology.proteinCandidate gene approachbusinessGeneral Economics Econometrics and FinanceCancers
researchProduct

Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.

2004

BACKGROUND Genes encoding enzymes involved in estrogen metabolism are held to be candidate genes for associations with breast disease. In these candidate genes, no critical combination of single-nucleotide polymorphisms (SNPs) for assessing breast carcinoma risk has been reported to date. METHODS In a large case–control study, the authors investigated 10 estrogen-metabolizing SNPs in 396 patients with breast carcinoma, 154 patients with fibroadenoma, and 1936 healthy control patients without breast carcinoma in their personal history. The following 10 SNPs were analyzed using sequencing-on-chip technology via a solid-phase polymerase chain reaction assay performed on oligonucleotide microar…

OncologyRiskCancer Researchmedicine.medical_specialtyCandidate geneSingle-nucleotide polymorphismBreast NeoplasmsPolymorphism Single NucleotideWhite PeopleGene FrequencyInternal medicineGenotypeCarcinomaCytochrome P-450 CYP1A1MedicineHumansGenetic Predisposition to Diseasebusiness.industryCarcinomaCancerSteroid 17-alpha-HydroxylaseEstrogensMiddle Agedmedicine.diseaseFibroadenomaEndocrinologyOncologyFibroadenomaCase-Control StudiesFemaleBreast diseasebusinessBreast carcinomaCancer
researchProduct

First results on dark matter annihilation in the Sun using the ANTARES neutrino telescope

2013

A search for high-energy neutrinos coming from the direction of the Sun has been performed using the data recorded by the ANTARES neutrino telescope during 2007 and 2008. The neutrino selection criteria have been chosen to maximize the selection of possible signals produced by the self-annihilation of weakly interacting massive particles accumulated in the centre of the Sun with respect to the atmospheric background. After data unblinding, the number of neutrinos observed towards the Sun was found to be compatible with background expectations. The 90% CL upper limits in terms of spin-dependent and spin-independent WIMP-proton cross-sections are derived and compared to predictions of two sup…

PHOTINOAstrophysicsMASSIVE PARTICLES01 natural sciencesLIMITSDirect searchCANDIDATESPhysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)Annihilationdark matter detectors[SDU.ASTR.HE]Sciences of the Universe [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]Particle physicsAstrophysics::Instrumentation and Methods for AstrophysicsCAPTURELIGHTparticle physics - cosmology connectionWeakly interacting massive particlesneutrino experiments; particle physics - cosmology connection; dark matter detectors; supersymmetry and cosmologyFísica nuclearNeutrinosupersymmetry andAstrophysics - High Energy Astrophysical PhenomenaCosmology connectionsupersymmetry and cosmologyFLUX[PHYS.ASTR.HE]Physics [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]Supersymmetry and cosmologydark matter detectorAstrophysics::High Energy Astrophysical PhenomenaNeutrino telescopeDark matterFOS: Physical sciencesddc:500.2neutrino experimentsSEARCH0103 physical sciencesDETECTORS010306 general physicsSelection (genetic algorithm)Dark matter detectors010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyAstronomy and AstrophysicsNeutrino experimentsFISICA APLICADAParticle physics - cosmology connectionneutrino experimentHigh Energy Physics::ExperimentcosmologySYSTEM
researchProduct

Parent of origin effects in attention/deficit hyperactivity disorder (ADHD): analysis of data from the international multicenter ADHD genetics (IMAGE…

2008

Contains fulltext : 71540.pdf (Publisher’s version ) (Closed access) There are conflicting reports suggesting that the parental origin of transmitted risk alleles may play a role in the etiology of attention deficit/hyperactivity disorder (ADHD). A recent report by Hawi and colleagues observed a generalized paternal over-transmission of alleles associated with ADHD. This was not replicated in more recent studies. Using data from a large multicenter study we examined the overall and gene-specific parent of origin effect in 554 independent SNPs across 47 genes. Transmission disequilibrium and explicit parent of origin test were performed using PLINK. Overall parent of origin effect was tested…

ParentsCandidate geneGenetics and epigenetic pathways of disease [NCMLS 6]2804 Cellular and Molecular NeuroscienceMedizinNeuroinformatics [DCN 3]Linkage Disequilibrium2738 Psychiatry and Mental Health0302 clinical medicineRisk FactorsPerception and Action [DCN 1]Genetics(clinical)Genetics (clinical)0303 health sciencesTPH210058 Department of Child and Adolescent PsychiatryPsychiatry and Mental healthData Interpretation StatisticalFunctional Neurogenomics [DCN 2]Clinical psychologyGenetic Markers2716 Genetics (clinical)Single-nucleotide polymorphism610 Medicine & healthMental health [NCEBP 9]Polymorphism Single NucleotideGenetic determinismGenomic disorders and inherited multi-system disorders [IGMD 3]Molecular epidemiology [NCEBP 1]03 medical and health sciencesCellular and Molecular NeuroscienceCognitive neurosciences [UMCN 3.2]Translational research [ONCOL 3]medicineAttention deficit hyperactivity disorderHumansFamilyGenetic Predisposition to Diseaseddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersAlleleAlleles030304 developmental biologyChi-Square DistributionEndocrinology and reproduction [UMCN 5.2]business.industrymedicine.diseaseGenetic defects of metabolism [UMCN 5.1]Multicenter studyAttention Deficit Disorder with HyperactivityEtiologybusiness030217 neurology & neurosurgeryAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
researchProduct

Search for Dark Matter Annihilations in the Sun with the 79-String IceCube Detector

2012

We have performed a search for muon neutrinos from dark matter annihilation in the center of the Sun with the 79-string configuration of the IceCube neutrino telescope. For the first time, the DeepCore sub-array is included in the analysis, lowering the energy threshold and extending the search to the austral summer. The 317 days of data collected between June 2010 and May 2011 are consistent with the expected background from atmospheric muons and neutrinos. Upper limits are therefore set on the dark matter annihilation rate, with conversions to limits on spin-dependent and spin-independent WIMP-proton cross-sections for WIMP masses in the range 20 - 5000 GeV. These are the most stringent s…

Particle physicsPhysics::Instrumentation and DetectorsAstrophysics::High Energy Astrophysical PhenomenaDark matterFOS: Physical sciencesGeneral Physics and AstronomyCosmic rayddc:500.2MASSIVE PARTICLESAstrophysics::Cosmology and Extragalactic AstrophysicsAstrophysics7. Clean energy01 natural sciencesIceCubeHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)LIMITSWIMP0103 physical sciencesddc:550010306 general physicsLight dark matterCANDIDATESHigh Energy Astrophysical Phenomena (astro-ph.HE)Physics010308 nuclear & particles physicsAstrophysics::Instrumentation and Methods for AstrophysicsCONSTRAINTSCAPTURENEUTRINOSPhysics and AstronomyNeutrino detector13. Climate actionWeakly interacting massive particlesHigh Energy Physics::ExperimentCryogenic Dark Matter SearchNeutrinoAstrophysics - High Energy Astrophysical PhenomenaPhysical Review Letters
researchProduct